Navigation Links
Upcoming Beckman Coulter Investor Events Second Half of 2008

ORANGE COUNTY, Calif., June 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.

-- Q2 2008 Earnings Release scheduled for Friday, July 25, 2008.

-- July 28 - 31, 2008, Washington, DC - The American Association for

Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition.

-- AACC will host its annual IVD Industry Analyst Briefing on Monday

afternoon, July 28, 2008, from 1:30 p.m. to 5:30 p.m. at the

Renaissance Marriott Hotel, Congressional Hall A. To RSVP, email:

-- Beckman Coulter will host an investor event Tuesday, July 29, from

7:30 a.m. to 9:00 a.m. To receive full details, RSVP directly to

Investor Relations at (714) 773-7620 or

-- Industry Exhibits open on Tuesday, July 29 to Thursday, July 31,

2008 at the Walter E. Washington Convention Center, Washington, DC.

-- For general meeting information, go to

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a live webcast of this event. It will be accessible

through Beckman Coulter's website.

-- The company will attend the following conference:

-- Thomas Weisel 2008 Healthcare Conference - Thursday, September 4,

2008, in Boston, Massachusetts.

-- Oppenheimer 19th Annual Healthcare Conference - Tuesday, November 4,

2008, in New York City, New York.

-- Lazard Capital Markets Healthcare Conference - Tuesday-Wednesday,

November 18-19, 2008, New York City, New York.

-- Piper Jaffray Conference - Tuesday-Wednesday, December 2-3, 2008,

New York City, New York.

Please refer to the company's website at for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit

Contact: Cynthia Skoglund, (714) 773-8213, or

Allan Harris, (714) 773-7620

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DURECT Corporation to Participate in Upcoming Healthcare Conferences
2. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
3. ViroPharma to Present at Two Upcoming Healthcare Conferences
4. Cynosure Announces Schedule of Upcoming Investor Conferences
5. Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
6. Martek to Present at Upcoming UBS Conference
7. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
8. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
9. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
10. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):